Combination Therapy for Age-Related Macular Degeneration.
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to investigate whether patients with Choroidal
Neovascularization secondary to Age-related Macular Degeneration, receiving triple or double
therapy compared to monotherapy with Avastin will reduce the intervention rate with
equivalent safety and efficacy.